Seo B, Kim D, Hwang H, Kim M, Ma S, Kwon S
Neuron. 2021; 109(23):3758-3774.e11.
PMID: 34644545
PMC: 8639668.
DOI: 10.1016/j.neuron.2021.09.031.
Kinyamu H, Bennett B, Bushel P, Archer T
J Biol Chem. 2019; 295(5):1271-1287.
PMID: 31806706
PMC: 6996893.
DOI: 10.1074/jbc.RA119.011174.
Oladimeji P, Cui H, Zhang C, Chen T
Expert Opin Drug Metab Toxicol. 2016; 12(9):997-1010.
PMID: 27295009
PMC: 4992434.
DOI: 10.1080/17425255.2016.1201069.
Olivares A, Moreno-Ramos O, Haider N
J Exp Neurosci. 2016; 9(Suppl 2):93-121.
PMID: 27168725
PMC: 4859451.
DOI: 10.4137/JEN.S25480.
Zhou W, Slingerland J
Nat Rev Cancer. 2014; 14(1):26-38.
PMID: 24505618
DOI: 10.1038/nrc3622.
Opening the black box: revealing the molecular basis of thyroid hormone transport.
Martagon A, Philips K, Webb P
Endocrinology. 2013; 154(7):2266-9.
PMID: 23794412
PMC: 3689275.
DOI: 10.1210/en.2013-1393.
Nuclear receptors and their selective pharmacologic modulators.
Burris T, Solt L, Wang Y, Crumbley C, Banerjee S, Griffett K
Pharmacol Rev. 2013; 65(2):710-78.
PMID: 23457206
PMC: 11060414.
DOI: 10.1124/pr.112.006833.
Emerging roles of the 26S proteasome in nuclear hormone receptor-regulated transcription.
Keppler B, Archer T, Kinyamu H
Biochim Biophys Acta. 2010; 1809(2):109-18.
PMID: 20728592
PMC: 3026859.
DOI: 10.1016/j.bbagrm.2010.08.005.
Identification of glucose transporter 4 knockdown-dependent transcriptional activation element on the retinol binding protein 4 gene promoter and requirement of the 20 S proteasome subunit for transcriptional activity.
Inoue E, Yamashita A, Inoue H, Sekiguchi M, Shiratori A, Yamamoto Y
J Biol Chem. 2010; 285(33):25545-53.
PMID: 20530491
PMC: 2919119.
DOI: 10.1074/jbc.M109.079152.
Selective estrogen receptor down-regulator and selective estrogen receptor modulators differentially regulate lactotroph proliferation.
Kansra S, Chen S, Bangaru M, Sneade L, Dunckley J, Ben-Jonathan N
PLoS One. 2010; 5(4):e10060.
PMID: 20419096
PMC: 2856675.
DOI: 10.1371/journal.pone.0010060.
Molecular aspects of thyroid hormone actions.
Cheng S, Leonard J, Davis P
Endocr Rev. 2010; 31(2):139-70.
PMID: 20051527
PMC: 2852208.
DOI: 10.1210/er.2009-0007.
Molecular cloning and characterization of the human PED/PEA-15 gene promoter reveal antagonistic regulation by hepatocyte nuclear factor 4alpha and chicken ovalbumin upstream promoter transcription factor II.
Ungaro P, Teperino R, Mirra P, Cassese A, Fiory F, Perruolo G
J Biol Chem. 2008; 283(45):30970-9.
PMID: 18765665
PMC: 2662169.
DOI: 10.1074/jbc.M803895200.
Physical and functional interactions of monoubiquitylated transactivators with the proteasome.
Archer C, Burdine L, Liu B, Ferdous A, Johnston S, Kodadek T
J Biol Chem. 2008; 283(31):21789-98.
PMID: 18515799
PMC: 2490782.
DOI: 10.1074/jbc.M803075200.
Genome wide transcriptional profiling in breast cancer cells reveals distinct changes in hormone receptor target genes and chromatin modifying enzymes after proteasome inhibition.
Kinyamu H, Collins J, Grissom S, Hebbar P, Archer T
Mol Carcinog. 2008; 47(11):845-85.
PMID: 18381591
PMC: 2863309.
DOI: 10.1002/mc.20440.
Intersection of nuclear receptors and the proteasome on the epigenetic landscape.
Kinyamu H, Jefferson W, Archer T
Environ Mol Mutagen. 2007; 49(1):83-95.
PMID: 18095329
PMC: 2482603.
DOI: 10.1002/em.20360.
Phosphorylation of activation function-1 regulates proteasome-dependent nuclear mobility and E6-associated protein ubiquitin ligase recruitment to the estrogen receptor beta.
Picard N, Charbonneau C, Sanchez M, Licznar A, Busson M, Lazennec G
Mol Endocrinol. 2007; 22(2):317-30.
PMID: 17962381
PMC: 2346536.
DOI: 10.1210/me.2007-0281.
Proteasome activity modulates chromatin modifications and RNA polymerase II phosphorylation to enhance glucocorticoid receptor-mediated transcription.
Kinyamu H, Archer T
Mol Cell Biol. 2007; 27(13):4891-904.
PMID: 17438138
PMC: 1951501.
DOI: 10.1128/MCB.02162-06.
Ubiquitin-interaction motifs of RAP80 are critical in its regulation of estrogen receptor alpha.
Yan J, Kim Y, Yang X, Albers M, Koegl M, Jetten A
Nucleic Acids Res. 2007; 35(5):1673-86.
PMID: 17311814
PMC: 1865050.
DOI: 10.1093/nar/gkl1112.
The role of the proteasomal ATPases and activator monoubiquitylation in regulating Gal4 binding to promoters.
Ferdous A, Sikder D, Gillette T, Nalley K, Kodadek T, Johnston S
Genes Dev. 2006; 21(1):112-23.
PMID: 17167105
PMC: 1759896.
DOI: 10.1101/gad.1493207.
Turning off estrogen receptor beta-mediated transcription requires estrogen-dependent receptor proteolysis.
Tateishi Y, Sonoo R, Sekiya Y, Sunahara N, Kawano M, Wayama M
Mol Cell Biol. 2006; 26(21):7966-76.
PMID: 16940184
PMC: 1636734.
DOI: 10.1128/MCB.00713-06.